The branch of Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) conducted consistency evaluation on generic drugs.

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Group Co., Ltd. (referred to as "Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory"), has received the approval notice for a drug supplementary application issued by the National Medical Products Administration. Azithromycin capsules have passed the evaluation of generic drug quality and efficacy consistency. It is reported that Azithromycin belongs to the macrolide antibiotics, with characteristics such as a broad spectrum of antibacterial activity, rapid oral absorption, and a long half-life. It is mainly used for the treatment of: (1) acute pharyngitis and acute tonsillitis caused by Streptococcus pyogenes; (2) sinusitis, otitis media, acute bronchitis, acute exacerbations of chronic bronchitis caused by sensitive bacteria; (3) pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae; (4) urethritis and cervicitis caused by Chlamydia trachomatis and non-multiple drug-resistant Neisseria gonorrhoeae; (5) skin and soft tissue infections caused by sensitive bacteria.